Sanjeev Jain – Akums Drugs& Pharmaceuticals Ltd

• Sanjeev Jain co-founded Akums Drugs & Pharmaceuticals Limited in April 2004, contributing to its establishment as a significant player in the pharmaceutical industry.
• Under Sanjeev Jain's leadership as Director, Akums has grown to become one of India's largest contract manufacturers of pharmaceutical products.
• Akums Drugs has developed a diverse range of products, enhancing its portfolio to include over 300 formulations across various therapeutic segments.
• Sanjeev Jain has overseen the implementation of state-of-the-art manufacturing processes, which have led to regulatory approvals from esteemed national and international organizations.
• The company has faced challenges in navigating the competitive pharmaceutical landscape, yet has successfully expanded its market presence domestically and internationally.
• Akums has received numerous awards and recognitions for quality and innovation in the pharmaceutical sector, highlighting the impact of Sanjeev Jain’s strategic vision.
• In response to market demands, Sanjeev Jain has driven the company's investments in research and development, leading to new product introductions and advancements in drug formulations.
• Sanjeev Jain has emphasized the importance of sustainability and social responsibility within the operations of Akums, promoting ethical practices and community engagement.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Akums Drugs& Pharmaceuticals Ltd corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Sanjeev Jain's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Akums Drugs& Pharmaceuticals Ltd's official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)